Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Almirall, Athenex, Cerovene, Cyclo, Janssen, Lilly, Mallinckrodt, Meiragtx, Morphosys, Pfizer, Prevail, Sanofi, Takeda, Virpax.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Biohaven, Boehringer Ingelheim, Debiopharm, Lilly, Fennec, Innocoll, Mereo, Shionogi, Takeda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Companion Medical.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baxter, Ibex, Upnride Robotics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acacia, GSK, Harbour, Kirin, Lilly, Steba, Tessa, Ultragenyx, Y-mabs, Zogenix.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CHF Solutions, Livanova, Senseonics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Kiadis, Puma, Translate Bio.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ascentage, Ascletis, Astellas, Bristol-Myers Squibb, Roche, Seattle Genetics, Seqirus, Takeda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Altair Medical, Asuragen, Avanos Medical, Cynosure, Emagine Solutions Technology, Emcyte, Fujifilm, Kurin, Zynex.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Genentech, Halozyme, Lysogene, Noxopharm.